TAGAMET HB LAUNCH PLAN INCLUDES MAILINGS TO 460,000 HEALTH PROFESSIONALS
This article was originally published in The Tan Sheet
Executive Summary
TAGAMET HB LAUNCH PLAN INCLUDES MAILINGS TO 460,000 HEALTH PROFESSIONALS to announce the availability of the OTC cimetidine product and to provide information on the drug's labeled indications, dosing, warnings and precautions, SmithKline Beecham Consumer Healthcare Products President-North America Jack Ziegler told a joint meeting of FDA's Nonprescription Drugs and Gastrointestinal Drugs Advisory Committees on July 27. "Immediately upon approval" of Tagamet HB, mailgrams will be sent to 300,000 physicians, 110,000 pharmacists and 50,000 allied health professionals, Ziegler said.